Vilazodone for the Treatment of Major Depressive Disorder: Focusing on Its Clinical Studies and Mechanism of Action
We tried to review and update clinical and preclinical studies evaluating vilazodone's role as an antidepressant for patients with major depressive disorder (MDD). In terms of its mechanism of actions, we sought to elaborate them mainly through preclinical animal studies. A data search was cond...
Main Authors: | , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Korean Neuropsychiatric Association
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390584/ |